Nurse Practitioner, Family · Des Moines, IA
NPI
1457681835
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
411 Laurel St Ste 2350
Des Moines, IA, 50314
Phone (515) 280-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
196 services
Medicare patients, 2024
94
Average age 66
Drug cost, 2024
$749K
1,778 prescriptions
Company payments, 2025
$554
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Astra F Fecundo was code 90961 (esrd related services (not dialysis)), 67 times for 44 patients. In total Maria Astra F Fecundo billed 196 services in 6 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90961 ESRD Related Services (not dialysis) | Office | 67 | 44 | $178.02 | $12K |
| 90962 ESRD Related Services (not dialysis) | Office | 56 | 40 | $124.12 | $6,951 |
| 90966 ESRD Related Services (not dialysis) | Office | 52 | 27 | $182.72 | $9,502 |
| 90960 ESRD Related Services (not dialysis) | Office | 12 | 12 | $220.98 | $2,652 |
By year: 2022 $20K for 125 services; 2023 $28K for 157 services; 2024 $33K for 196 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Astra F Fecundo prescribed most often to Medicare patients was Sevelamer Carbonate, with 184 prescriptions and refills. In total Maria Astra F Fecundo wrote 1,778 Medicare prescriptions that cost $749K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 184 | 288 | 60 | $53K |
| Velphoro Sucroferric Oxyhydroxide | 140 | 164 | 39 | $424K |
| Amlodipine Besylate Generic | 114 | 218 | 27 | $601 |
| Calcium Acetate Generic | 109 | 166 | 35 | $9,902 |
| Carvedilol Generic | 93 | 187 | 30 | $629 |
| Lanthanum Carbonate Generic | 92 | 138 | 28 | $101K |
| Furosemide Generic | 91 | 182 | 33 | $570 |
| Lisinopril Generic | 89 | 189 | 28 | $659 |
| Bumetanide Generic | 83 | 184 | 27 | $5,509 |
| Hydralazine Hcl Generic | 66 | 146 | 21 | $1,273 |
| Gabapentin Generic | 51 | 57 | 11 | $389 |
| Doxazosin Mesylate Generic | 51 | 109 | 15 | $1,143 |
| Torsemide Generic | 41 | 103 | 17 | $747 |
| Potassium Chloride Generic | 39 | 73 | 12 | $2,457 |
| Metoprolol Succinate Generic | 38 | 100 | 16 | $500 |
Brand drugs: 242 claims; generic drugs: 1,536 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Astra F Fecundo $554 ($554 in general payments such as food, travel and fees) from 10 companies. The largest payer was Fresenius USA Marketing, Inc. with $157.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 12 | $157 |
| Ardelyx, Inc. ARDX | 1 | $110 |
| Calliditas Therapeutics US Inc. | 2 | $77.87 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $51.9 |
| Amgen Inc. AMGN | 2 | $34.13 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.61 |
| Travere Therapeutics, Inc. TVTX | 1 | $28.42 |
| Novo Nordisk Inc NVO | 1 | $22.3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.51 |
| Vifor Pharma, Inc. | 1 | $19.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.